Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Free Subscription


1 Clin Infect Dis
1 Infect Immun
2 J Immunol
4 J Infect Dis
1 J Virol
1 Lancet
1 MMWR Morb Mortal Wkly Rep
1 Nat Med
4 Pediatr Infect Dis J
5 PLoS One
1 Proc Natl Acad Sci U S A
6 Science
18 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Clin Infect Dis

  1. MARTINEZ-BAZ I, Navascues A, Portillo ME, Casado I, et al
    Effect of influenza vaccination in preventing laboratory-confirmed influenza hospitalization in patients with diabetes mellitus.
    Clin Infect Dis. 2020 May 15. pii: 5837528. doi: 10.1093.
    PubMed         Abstract available

    Infect Immun

  2. JELINSKI J, Terwilliger A, Green S, Maresso A, et al
    Progress Towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model.
    Infect Immun. 2020 May 11. pii: IAI.00082-20. doi: 10.1128/IAI.00082.
    PubMed         Abstract available

    J Immunol

  3. HELMOLD HAIT S, Hogge CJ, Rahman MA, Ko EJ, et al
    An SAMT-247 Microbicide Provides Potent Protection against Intravaginal Simian Immunodeficiency Virus Infection of Rhesus Macaques, whereas an Added Vaccine Component Elicits Mixed Outcomes.
    J Immunol. 2020 May 11. pii: jimmunol.2000165. doi: 10.4049/jimmunol.2000165.
    PubMed         Abstract available

  4. ADAM L, Tchitchek N, Todorova B, Rosenbaum P, et al
    Innate Molecular and Cellular Signature in the Skin Preceding Long-Lasting T Cell Responses after Electroporated DNA Vaccination.
    J Immunol. 2020 May 8. pii: jimmunol.1900517. doi: 10.4049/jimmunol.1900517.
    PubMed         Abstract available

    J Infect Dis

  5. YUILL S, Egger S, Smith M, Velentzis L, et al
    Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia.
    J Infect Dis. 2020 May 9. pii: 5827184. doi: 10.1093.
    PubMed         Abstract available

  6. BARTSCH SM, Mitgang EA, Geller G, Cox SN, et al
    What if the Influenza Vaccine Did Not Offer Such Variable Protection?
    J Infect Dis. 2020 May 9. pii: 5835317. doi: 10.1093.
    PubMed         Abstract available

  7. TCHALLA EYI, Bhalla M, Wohlfert EA, Bou Ghanem EN, et al
    Neutrophils are required during immunization with the pneumococcal conjugate vaccine for protective antibody responses and host defense against infection.
    J Infect Dis. 2020 May 11. pii: 5835638. doi: 10.1093.
    PubMed         Abstract available

  8. COWLING BJ, Thompson MG, Ng TWY, Fang VJ, et al
    Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults.
    J Infect Dis. 2020 May 14. pii: 5837136. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  9. SCHNEIDER M, Muller M, Yigitliler A, Xi J, et al
    An Orf Virus-based therapeutic vaccine for the treatment of papillomavirus-induced tumors.
    J Virol. 2020 May 13. pii: JVI.00398-20. doi: 10.1128/JVI.00398.
    PubMed         Abstract available


  10. HAMIEL U, Kozer E, Youngster I
    SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults.
    JAMA. 2020 May 13. pii: 2766182. doi: 10.1001/jama.2020.8189.

  11. Serums and Vaccines in Influenza.
    JAMA. 2020;323:1858.


  12. WHITEHEAD CL, Walker SP
    Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.
    Lancet. 2020 May 13. pii: S0140-6736(20)31029.

    MMWR Morb Mortal Wkly Rep

  13. SANTOLI JM, Lindley MC, DeSilva MB, Kharbanda EO, et al
    Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:591-593.
    PubMed         Abstract available

    Nat Med

  14. ARUNACHALAM PS, Charles TP, Joag V, Bollimpelli VS, et al
    T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.
    Nat Med. 2020 May 11. pii: 10.1038/s41591-020-0858.
    PubMed         Abstract available

    Pediatr Infect Dis J

    Will Infant Hepatitis B Immunization Protect Adults?
    Pediatr Infect Dis J. 2019;38.
    PubMed         Abstract available

  16. MITCHELL HK, Mokomane M, Leeme T, Tlhako N, et al
    Causes of Pediatric Meningitis in Botswana: Results From a 16-Year National Meningitis Audit.
    Pediatr Infect Dis J. 2019 Jun 21. doi: 10.1097/INF.0000000000002396.
    PubMed         Abstract available

  17. ESPOSITO S, Fling J, Chokephaibulkit K, de Bruijn M, et al
    Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial.
    Pediatr Infect Dis J. 2020 May 12. doi: 10.1097/INF.0000000000002727.
    PubMed         Abstract available

  18. PALMU AA, Rinta-Kokko H, Nohynek H, Nuorti JP, et al
    Indirect Impact of Ten-valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.
    Pediatr Infect Dis J. 2020 May 13. doi: 10.1097/INF.0000000000002696.
    PubMed         Abstract available

    PLoS One

  19. LIM W, Zhang P
    Herd immunity and a vaccination game: An experimental study.
    PLoS One. 2020;15:e0232652.
    PubMed         Abstract available

  20. ITO H, Nishimura H, Kisu T, Hagiwara H, et al
    Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic.
    PLoS One. 2020;15:e0233001.
    PubMed         Abstract available

  21. SPRYGIN A, Pestova Y, Bjadovskaya O, Prutnikov P, et al
    Evidence of recombination of vaccine strains of lumpy skin disease virus with field strains, causing disease.
    PLoS One. 2020;15:e0232584.
    PubMed         Abstract available

  22. NAMAKULA R, de Bree LCJ, A Tvedt TH, Netea MG, et al
    Monocytes from neonates and adults have a similar capacity to adapt their cytokine production after previous exposure to BCG and beta-glucan.
    PLoS One. 2020;15:e0229287.
    PubMed         Abstract available

  23. CASTRO JT, Oliveira GS, Nishigasako MA, Debrie AS, et al
    Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A.
    PLoS One. 2020;15:e0228055.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  24. HLADISH TJ, Pearson CAB, Toh KB, Rojas DP, et al
    Designing effective control of dengue with combined interventions.
    Proc Natl Acad Sci U S A. 2020;117:3319-3325.
    PubMed         Abstract available


  25. KAISER J
    NIH organizes hunt for drugs.
    Science. 2020;368:351.

  26. COREY BL, Mascola JR, Fauci AS, Collins FS, et al
    A strategic approach to COVID-19 vaccine R&D.
    Science. 2020 May 11. pii: science.abc5312. doi: 10.1126/science.abc5312.
    PubMed         Abstract available

    Rapid COVID-19 vaccine development.
    Science. 2020 May 8. pii: science.abb8923. doi: 10.1126/science.abb8923.
    PubMed         Abstract available

  28. COHEN MS, Corey L
    Combination prevention for COVID-19.
    Science. 2020;368:551.

  29. LONDON AJ, Kimmelman J
    Against pandemic research exceptionalism.
    Science. 2020;368:476-477.

  30. COHEN J
    U.S. 'Warp Speed' vaccine effort comes out of the shadows.
    Science. 2020;368:692-693.


  31. WAGNER AL, Gordon A, Tallo VL, Simaku A, et al
    Intent to obtain pediatric influenza vaccine among mothers in four middle income countries.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30508.
    PubMed         Abstract available

  32. SMITH LE, Amlot R, Weinman J, Yiend J, et al
    Why do parents not re-vaccinate their child for influenza? A prospective cohort study.
    Vaccine. 2020 May 5. pii: S0264-410X(20)30509.
    PubMed         Abstract available

  33. NOUATIN O, Ateba Ngoa U, Ibanez J, Dejon-Agobe JC, et al
    Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.
    Vaccine. 2020 May 5. pii: S0264-410X(20)30540.
    PubMed         Abstract available

  34. BATMUNKH T, Dalmau MT, Munkhsaikhan ME, Khorolsuren T, et al
    A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30534.
    PubMed         Abstract available

  35. PALLIKKUTH S, Bolivar H, Fletcher MA, Babic DZ, et al
    A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30485.
    PubMed         Abstract available

    Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development.
    Vaccine. 2020 May 1. pii: S0264-410X(20)30590.

  37. ESTEVES-JARAMILLO A, Koehler T, Jeanfreau R, Neveu D, et al
    Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in >/=56-year-olds: A Phase III randomized study.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30584.
    PubMed         Abstract available

  38. JONES OS, Vassie C, Emanuel O, Lechner M, et al
    Targeting key groups using a low-cost strategy to increase HPV awareness and vaccine uptake.
    Vaccine. 2020;38:4059.

  39. XIAO X, Wong RM
    Vaccine hesitancy and perceived behavioral control: A meta-analysis.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30593.
    PubMed         Abstract available

  40. ORTA OR, Hatch EE, Regan AK, Perkins R, et al
    A prospective study of influenza vaccination and time to pregnancy.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30548.
    PubMed         Abstract available

  41. DEAN TC, Gilliland AE, Cameron JE
    Parents' receptiveness to oral health clinic-based vaccination.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30535.
    PubMed         Abstract available

  42. SREEVATSAVA M, Burman AL, Wahdan A, Safdar RM, et al
    Routine immunization coverage in Pakistan: a survey of children under 1 year of age in community-based vaccination areas.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30585.
    PubMed         Abstract available

  43. MORGENROTH A, Jakel V, Hanke-Robinson H, Muller T, et al
    A novel electrophoretic immunoblot as antigen desorption and quantification method for alum-adjuvanted veterinary rabies vaccines.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30561.
    PubMed         Abstract available

  44. KAUR R, Pichichero M
    Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30580.
    PubMed         Abstract available

  45. MALTEZOU HC, Asimakopoulos G, Stavrou S, Daskalakis G, et al
    Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30564.
    PubMed         Abstract available

  46. WON G, Senevirathne A, Lee JH
    Salmonella Enteritidis ghost vaccine carrying the hemagglutinin globular head (HA1) domain from H1N1 virus protects against salmonellosis and influenza in chickens.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30594.
    PubMed         Abstract available

  47. WEBBER C, Peyrani P, Balmer P, Serra L, et al
    Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30260.
    PubMed         Abstract available

  48. NEUFEIND J, Betsch C, Habersaat KB, Eckardt M, et al
    Barriers and drivers to adult vaccination among family physicians - Insights for tailoring the immunization program in Germany.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30546.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.